Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

293031323334353637

AstraZeneca's Ultomiris approved in EU for autoimmune disease NMOSD

10th May 2023 08:50

(Alliance News) - AstraZeneca PLC on Wednesday said the European Commission approved its drug Ultomiris in the EU for adults with autoimmune disease neuromyelitis optica spectrum disorder, known as NMOSD. Read More

LONDON BROKER RATINGS: RBC raises Intertek; Davy likes Greencoat UK

9th May 2023 09:29

(Alliance News) - The following London-listed shares received analyst recommendations xxxxday morning: Read More

TOP NEWS: AstraZeneca's Farxiga approved in US to treat heart failure

9th May 2023 09:09

(Alliance News) - AstraZeneca PLC on Tuesday said its Farxiga drug has been approved by the US Food & Drug Administration to reduce the risk of cardiovascular death and hospitalisation for heart failure in adults. Read More

IN BRIEF: AstraZeneca Chair Michel Demare buys GBP230,000 in shares

2nd May 2023 14:28

AstraZeneca PLC - Cambridge, England-based biopharmaceutical maker - Non-Executive Chair Michel Demare buys 2,000 shares at GBP117.01, worth GBP234,020, on Friday last week. Read More

AstraZeneca bemoans ODAC judgement on use of Lynparza drug for cancer

2nd May 2023 09:06

(Alliance News) - AstraZeneca PLC on Tuesday bemoaned the results of a regulatory meeting held by the US Food & Drug Administration, which suggested its Lynparza prostate cancer treatment should be limited to tumours with a BRCA mutation. Read More

AstraZeneca "disappointed" with US ODAC's guidance on Lynparza

1st May 2023 12:35

(Alliance News) - AstraZeneca PLC on Friday said the US Food & Drug Administration's Oncologic Drugs Advisory Committee has recognised a favourable benefit risk profile for its Lynparza, plus abiraterone and prednisone or prednisolone, for the treatment of adult patients with BRCA-mutated metastatic castration-resistant prostate cancer. Read More

TOP NEWS: AstraZeneca profit jumps despite Covid-19 sales decline

27th Apr 2023 09:26

(Alliance News) - AstraZeneca PLC on Thursday said revenue decreased in the first quarter of the year as Covid-19 related sales dropped, but pretax profit surged. Read More

LONDON MARKET OPEN: Stocks lower amid worries for health of US economy

27th Apr 2023 09:05

(Alliance News) - Stock prices in London opened lower on Thursday, with the FTSE 100 failing to get a boost by positive first-quarter results from major constituents including Barclays and AstraZeneca. Read More

LONDON BRIEFING: AstraZeneca revenue dips as Covid medicines decline

27th Apr 2023 07:52

(Alliance News) - Stocks in London were set to open lower on Thursday, as investors concern continued to mount about the health of the US banking sector after another largely lower finish in New York. Read More

LONDON MARKET CLOSE: Tech shines but tepid trade elsewhere

26th Apr 2023 17:03

(Alliance News) - European equities closed lower on Wednesday, with lingering banking sector worries hurting sentiment, while tech stocks outperformed wider markets in New York after well-received earnings overnight. Read More

UK earnings, trading statements calendar - next 7 days

20th Apr 2023 15:41

Read More

UK shareholder meetings calendar - next 7 days

20th Apr 2023 15:39

Read More

LONDON BRIEFING: Possible offers for Network International, John Wood

17th Apr 2023 07:52

(Alliance News) - Stock prices in London were called higher on Monday, following Asian equities into the green. Read More

AstraZeneca reports positive results for lung cancer drug combination

17th Apr 2023 06:45

(Alliance News) - AstraZeneca PLC on Sunday announced that a phase three trial showed that its Imfinzi treatment, in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery, had positive results in non-small cell lung cancer. Read More

TOP NEWS: AstraZeneca Covid antibody neutralises variants of concern

14th Apr 2023 08:24

(Alliance News) - AstraZeneca PLC on Friday said that its investigational Covid long-acting antibody AZD3152 neutralises all known variants of concern. Read More

LONDON BROKER RATINGS: Redburn likes Shell; Barclays raises Persimmon

11th Apr 2023 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday and over the long Easter weekend: Read More

TOP NEWS: Sanofi wins US drug control from AstraZeneca in Sobi deal

11th Apr 2023 08:57

(Alliance News) - AstraZeneca PLC on Tuesday said it has simplified its contract with Sanofi SA and Swedish Orphan Biovitrum, or Sobi, relating to the development and commercialisation of nirsevimab in the US, while Sanofi has also refiled its premerger form for its acquisition of Provention Bio Inc. Read More

LONDON BRIEFING: Harbour Energy, BP to team up on carbon capture

11th Apr 2023 07:55

(Alliance News) - Stocks in London are called to open higher on Tuesday, with European markets expected to begin the abbreviated week strongly following the long Easter weekend. Read More

LONDON MARKET CLOSE: Stocks end shortened week on positive note

6th Apr 2023 17:03

(Alliance News) - Stocks in London closed higher on Thursday, ahead of the long Easter weekend, defying gloomy local data as well as increasing expectations of a global economic slowdown. Read More

LONDON MARKET OPEN: European stocks edge higher in cautious trade

6th Apr 2023 08:37

(Alliance News) - Stock prices in London opened higher on Thursday, but sentiment was fragile amid fears of an economic slowdown in the US, and heightened geopolitical tensions. Read More

293031323334353637
FTSE 100 Latest
Value10,126.78
Change-68.57